Search
for
Sort by
Research 30 of 199
- Orthostatic symptoms in women treated with low-dose oral minoxidil in the absence of overt hypotension: Implications for clinical practice
- Medikamentöse Therapie des benignen Prostatasyndroms
- Finasteride in Androgenic Alopecia
- 103 The Effect of Evening Alcohol Consumption and Bedtime Administration of Flibanserin on the Safety of Flibanserin
- Minoxidil in severe hypertension with renal failure
- Spironolactone treatment for dermatologic indications is not associated with hypotension in a single-center retrospective study
- Severe cardiac conduction abnormalities associated with atypical toxic shock syndrome
- Pramipexole
- [A case of generalized komuragaeri disease (Satoyoshi disease) treated with glucocorticoid].
- Minoxidil in Severe Hypertension
- Effect of minoxidil on blood pressure and hemodynamics in severe hypertension
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Hypertension's 3 Dilemmas and 3 Solutions: Pharmacology of the Kidney in Hypertension
- Postural orthostatic tachycardia syndrome: a dermatologic perspective and successful treatment with losartan.
- Minoxidil overdose with ecg changes: Case report and review
- A hairy fall: syncope resulting from topical application of minoxidil
- Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
- Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations
- Agent: Minoxidil
- Direct Vasodilators and Sympatholytic Agents
- Secondary Adrenal Insufficiency : A Case Report
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- A Case of the Cons: How Contraception Confused Congenital Adrenal Hyperplasia for Conn
- A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms.
- Risks and side effects in the medical management of benign prostatic hyperplasia
- Targeting integrin pathways: mechanisms and advances in therapy
- 105 Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Genital Arousal Disorder